text: (R)-Roscovitine (<< CYC202 >>, Seliciclib) is a relatively selective inhibitor of [[ cyclin-dependent kinases ]] (CDKs), currently evaluated for the treatment of cancers, neurodegenerative disorders, renal diseases, and several viral infections.